AuntMinnie

OCTOBER 14, 2024

These SSTRs can be targeted both with gallium-68 (Ga-68) imaging agents and therapeutic lutetium-177 (Lu-177) radiopharmaceuticals using a so-called theranostics approach. Meningiomas are the most common primary adult intracranial tumors and most meningiomas show high expression of somatostatin receptors (SSTRs). In the U.S.,

Nuclear Medicine 276

Nuclear Medicine Radiopharmaceuticals Insurance Clinic 276

AuntMinnie

NOVEMBER 4, 2024

Centers for Medicare & Medicaid Services (CMS) 2025 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) final rules. Although the 2025 MPFS calls for an overall 2.9% The change to the MPFS conversion factor reflects the 0% update required by statute for 2025, the expiration of the 2.9%

Radiation Oncology 200

Radiation Oncology Nuclear Medicine Medicare Imaging 200

AuntMinnie

JANUARY 17, 2025

The mutual aim of the collaboration is to jointly establish commercial supply chains that can be accessed by radiopharmaceutical drug developers for clinical trials and commercial applications, according to Nusano.

Radiopharmaceuticals 130

Radiopharmaceuticals Clinic Medical IT 130

AuntMinnie

FEBRUARY 19, 2025

Food and Drug Administration (FDA) for its copper-67 (Cu-67) SAR-bisPSMA radiopharmaceutical for treating advanced prostate cancer. The radiopharmaceutical and imaging agent are a theranostics pair in development for use in patients from initial to late-stage disease, the company noted.

Radiopharmaceuticals 130

Radiopharmaceuticals Pharmaceutical Disease Diagnostic Imaging 130

AuntMinnie

JULY 10, 2024

Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).

Medicare 130

Medicare Nuclear Medicine Radiopharmaceuticals Imaging 130

Imaging Technology

JANUARY 27, 2025

tim.hodson Mon, 01/27/2025 - 10:11 Jan. Driving Accessible Precision Oncology UCSF and GE HealthCare hope to develop quantitative imaging methods to monitor patient response to radiopharmaceutical therapies (RPTs) and create protocols to expand access to these emerging treatments.

Healthcare 59

Healthcare Healthcare Magnetic Resonance Imaging Radiopharmaceuticals 59

AuntMinnie

SEPTEMBER 22, 2024

and distributes PET, SPECT, and therapeutic radiopharmaceuticals through 31 radiopharmacies across 18 states, Telix said. Telix Pharmaceuticals has inked a deal to acquire Florida-based radiopharmacy network RLS Radiopharmacies for up to $250 million, the companies announced.

Radiopharmaceuticals 130

Radiopharmaceuticals Pharmaceutical Diagnostic IT 130

AuntMinnie

JANUARY 28, 2025

Lantheus Holdings plans to acquire theranostic radiopharmaceutical manufacturer Evergreen Theragnostics for an upfront payment of $250 million and up to $752.5 The transaction is expected to close in the second half of 2025, according to Lantheus. million in potential milestone payments.

Radiopharmaceuticals 100

Radiopharmaceuticals Diagnostic Clinic IT 100

Imaging Technology

FEBRUARY 5, 2025

tim.hodson Wed, 02/05/2025 - 09:56 Feb. 5, 2025 Serac Healthcare Ltd., Wednesday, February 5, 2025 - 09:56 The company is now finalizing the protocol and will be working with the FDA to prepare for the start of the Phase III program. For more imformation, please visit www.serachealthcare.com.

Healthcare 52

Healthcare Healthcare Computed Tomography Imaging 52

Imaging Technology

JANUARY 30, 2025

tim.hodson Thu, 01/30/2025 - 10:20 Jan.30, 30, 2025 Earlier this month, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimers Association released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias.

Nuclear Medicine 52

Nuclear Medicine Imaging Patient Care Disease 52

Imaging Technology

JANUARY 5, 2024

milla1cf Fri, 01/05/2024 - 11:32 January 5, 2024 — NorthStar Medical Radioisotopes, LLC , a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc. Chief Executive Officer of NorthStar Medical Radioisotopes.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Nuclear Medicine Pharmaceutical 52

Imaging Technology

NOVEMBER 1, 2024

We also expect to see the full Phase 1 results presented at a scientific meeting in 2025." "The Dosimetry of [ 177 Lu] Lu-PSMA-Targeted Radiopharmaceutical Therapies in Patients with Prostate Cancer: A Comprehensive Systematic Review and Meta analysis." We remain on track for the opening of Phase 2 in the next few months.

Nuclear Medicine 52

Nuclear Medicine Radiation Radiopharmaceuticals Clinic 52

Imaging Technology

JULY 5, 2024

Lantheus intends to begin a Phase 1/2a study with 177Lu-DOTA-RM2 in prostate cancer patients in 2025. mtaschetta-millane Fri, 07/05/2024 - 06:00 July 5, 2024 — Lantheus Holdings, Inc. , 68Ga-DOTA-RM2 will be used as a companion diagnostic.

Diagnostic 105

Diagnostic Radiopharmaceuticals Disease IT 105

Imaging Technology

JUNE 13, 2024

An expanded Knowledge Bowl drew a packed crowd as teams showed off their smarts to compete for free registration for the 2025 Annual Meeting. Carson , PhD, and colleagues for their abstract “Exceptional Brain PET Images from the NeuroEXPLORER: Scans with Targeted Radiopharmaceuticals and Comparison to HRRT.” Wagner, Jr.,

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Education Imaging 105

Imaging Technology

APRIL 3, 2023

Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit. Ac-225 using advanced, environmentally preferable electron accelerator technology.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

Imaging Technology

JULY 20, 2023

Dr. Keole will serve one year as President-elect, followed by a year as President where he will oversee the 2025 ASTRO Annual Meeting; he then will serve one-year terms as Board Chair and Immediate Past Chair.

Radiation Oncology 98

Radiation Oncology Radiation Government Community Practice 98

AuntMinnie

OCTOBER 2, 2024

tesla MRI AI body composition analysis Cardiac PET Cryo/thermoablation CT colonography Genicular artery embolization Hyperpolarized xenon-129 MRI PET/MRI Photon-counting CT Radiomics Theranostics Whole-body MRI screening Image of the Year 3D PET/MR image.

Digital Imaging and Communications in Medicine 360

Digital Imaging and Communications in Medicine X-ray MRI Hospital 360

Imaging Technology

JANUARY 14, 2025

tim.hodson Tue, 01/14/2025 - 16:48 Jan.8, 8, 2025 The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimers Association have released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias.

Nuclear Medicine 52

Nuclear Medicine Imaging Patient Care PET Scan 52